Pancreatitis PostCPRE (PPC)
Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2019 – May 2020Where it's discussed
-
X / Twitter17 posts
-
Facebook2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions briefly mention 'Pancreatitis PostCPRE' and similar terms, suggesting a focus on the medical condition itself rather than detailed critique or insights. The tone remains neutral and matter-of-fact, reflecting a basic level of engagement with the publication's implications.
The posts are minimal and do not clearly support or oppose the conclusions, indicating neutrality.
There is some curiosity about pancreatitis post-ERCP, but the discussion remains limited.
The posts seem brief, mentioning the condition without deep analysis or personal opinions.
Given the sparse discussion, it appears the conversation has minimal influence on broader clinical practices.
Abstract in brief
- This study compared two methods to prevent pancreatitis after ERCP in high-risk patients: one using pancreatic duct stenting combined with medication, and the other using medication alone.
- The results showed similar rates and severity of post-ERCP pancreatitis in both groups, indicating that medication alone might be just as effective as adding stenting.
- Overall, the study did not find enough evidence to prove that medication alone is better or worse than combining it with stenting for preventing pancreatitis in these high-risk patients.]
Top posts
Most liked on X and BlueskyRT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
All mentions
Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for ...
Comparing Pharmacological and Stenting Prophylaxis for Post-ERCP Pancreatitis
This study compares medication alone versus combined with stenting to prevent pancreatitis after ERCP in high-risk patients. Results show similar effectiveness, suggesting medication alone may be sufficient for…
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
RT @RodriguezParra_: Pancreatitis PostCPRE (PPC)
Pancreatitis PostCPRE (PPC)
AM
DM
DC
RJ
SG
B
AH
DP
F
DP
MR
D
FX
DL
LA
M
AC